MBX Biosciences, Inc. MBX
NASDAQ · United States · Health Technology
$56.55-2.07 (-3.53%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.78 | -0.63 | -23.3% | $0 | — | +0.5%$67.48→$67.82 |
| Q1 2026 | 2026-05-07 | -0.51 | -0.62 | +17.7% | — | — | +27.5%$32.12→$40.97 |
| Q4 2025 | 2026-03-12 | -0.49 | -0.60 | +18.3% | — | — | -3.2%$28.94→$28.00 |
| Q3 2025 | 2025-11-06 | -0.63 | -0.73 | +13.7% | — | — | +13.4%$22.55→$25.57 |
| Q1 2025 | 2025-05-12 | -0.71 | -0.77 | +7.8% | — | — | — |
| Q4 2024 | 2025-03-17 | -0.47 | -0.59 | +20.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.